Stay updated on PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The study record now presents details of the completed pembrolizumab-versus-chemotherapy trial, including participant criteria, treatment arms, outcome measures, record dates, and a related publication. The previous access-denied error and NIH transition notice are no longer shown.
    Difference
    61%
    Check dated 2026-11-09T13:50:46.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:47:09.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition to using “Super Intelligence” instead of “Artificial Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T16:31:07.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The website footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T20:43:01.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-13T03:56:04.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error with the site header and footer visible, replacing the previously accessible study content and related documents.
    Difference
    20%
    Check dated 2026-09-21T22:36:18.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.